Biotechnology Progress

Papers
(The H4-Index of Biotechnology Progress is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Lignin degradation by microorganisms: A review60
Developments of biobased plasticizers for compostable polymers in the green packaging applications: A review47
A novel pH‐responsive nanoniosomal emulsion for sustained release of curcumin from a chitosan‐based nanocarrier: Emphasis on the concurrent improvement of loading, sustained release, and ap44
Proliferation and differentiation of primary bovine myoblasts using Chlorella vulgaris extract for sustainable production of cultured meat32
Computational drug repurposing study of the RNA binding domain of SARS‐CoV‐2 nucleocapsid protein with antiviral agents30
In vitro hepatic steatosis model based on gut–liver‐on‐a‐chip29
Economic assessment of continuous processing for manufacturing of biotherapeutics27
Green and sustainable route for oxidative depolymerization of lignin: New platform for fine chemicals and fuels27
Identification and characterization of a residual host cell protein hexosaminidase B associated with N‐glycan degradation during the stability study of a therapeutic recombinant monoclonal anti23
Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals23
Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak23
Synthesis of a novel nanocomposite containing chitosan as a three‐dimensional printed wound dressing technique: Emphasis on gene expression22
The effect of biosynthesized selenium nanoparticles on the expression of CYP51A and HSP90 antifungal resistance genes in Aspergillus fumigatus and Aspergi21
Deep brain stimulation: Challenges at the tissue‐electrode interface and current solutions21
Advances in 3D printing of composite scaffolds for the repairment of bone tissue associated defects21
Process and operations strategies to enable global access to antibody therapies20
Development of a targeted integration Chinese hamster ovary host directly targeting either one or two vectors simultaneously to a single locus using the Cre/Lox recombinase‐mediated cassette exchange 19
Aptamer‐functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: A comprehensive overview of recent trends19
In silico process characterization for biopharmaceutical development following the quality by design concept18
Using microalgae for remediation of crude petroleum oil–water emulsions18
Raman based chemometric model development for glycation and glycosylation real time monitoring in a manufacturing scale CHO cell bioreactor process18
Anti‐epithelial cell adhesion molecule RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model18
0.11040091514587